-
Regeneron PharmaceuticalsThe treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone. -
Noah Berger/FR34727 APThe cuts follow losses in two pivotal court cases and the company's push to invest in artificial intelligence.
-
The soaring cost of jet fuel is forcing European airlines to cancel tens of thousands of flights, while energy authorities warned of a possible jet fuel shortage if supplies aren't replenished soon. -
The White House Correspondents' Dinner will be headlined by a mentalist instead of a comedian. Oz Pearlman tells NPR he hopes to unify, delight and puzzle the crowd — but can't reveal how. -
The rising country star Ella Langley rules both the album and song charts this week, but Justin Bieber also sees a rise in popularity following his nostalgic performance at Coachella. -
Thomas led the San Francisco Symphony from 1995 to 2020, helping to establish its reputation as a world-class orchestra. In 2021, he was diagnosed with glioblastoma multiforme, a type of brain cancer.
Smith Collection
/
Gado via Getty Images
A new study looks at an unexpected force that played a critical role in shaping the lives of ancient humans.
Justin Sullivan
/
Getty Images
Mohammed Zaatari
/
AP
-
After a year without data, the State Department released figures on PEPFAR, the program launched by George W. Bush and credited with saving millions of lives. How did Trump's aid cuts affect it? -
The AI models and chatbots that we interact with tend to affirm our feelings and viewpoints — more so than people do, with potentially worrisome consequences. -
Americans who moved to Vietnam and Thailand say their lives are now lower-stress and lower-cost. But glamorous videos on TikTok don't tell the whole story. -
The executive director of World Press Photo said the image shows the inconsolable grief of children losing their father in a place built for justice. It is a stark and necessary record of family separation following the U.S. reform policies. -
The latest campaign finance reports show Democratic enthusiasm in key House and Senate races, but national Republican groups have far more in the bank to potentially spend down the road.
